Emisphere Technologies Inc., of Roseland, today announced it has agreed with Novo Nordisk A/S to amend the two companies' development and license agreement to develop and commercialize a drug candidate, to treat Type 2 diabetes, that uses Emisphere's Eligen technology.
Read More »
Health Care
Bayer announces 1.1B merger with Conceptus
Wayne-based Bayer HealthCare LLC announced today it will acquire Conceptus Inc., the Mountain View, Calif.-based developer of the Essure procedure, as it broadens its portfolio in contraception.
Read More »Advance Realty acquires Sanofi site in Bridgewater
Advance Realty and a Boston-based investment partner have acquired the former Sanofi U.S. research and development complex in Bridgewater, where the Bedminster-based developer will soon relocate its headquarters, the companies announced today.
Read More »Children’s hospital installs online system to give families daily updates
Children's Specialized Hospital in New Brunswick is the first rehabilitation children's hospital to equip its patient rooms with an interactive online system that provides families with daily clinical updates and educational tutorials, while giving young patients movies, games and e-mail to help pass the time.
Read More »Nymox enrolls patients for new study
Hasbrouck Heights-based Nymox Pharmaceutical Corp. announced it has enrolled the first patient in a company study of the safety and efficacy of NX-1207 reinjection for the treatment of prostate enlargement, according to a release.
Read More »NFL Alumni Association partners with pharma company on brain injury research
The National Football League Alumni Association, based in Newark, is working with Neuralstem, Inc. to develop a trial for treating NFL alumni members suffering from traumatic brain injuries, according to a release.
Read More »
Shining a light in a dark industry
Novo Nordisk's new headquarters is flooded with natural light, a result of a deliberate design decision to maximize exposure to sunshine. It's a feature that becomes immediately apparent as you navigate the company's vast, three-story complex off Route 1, in Plainsboro.
Read More »PTC Therapeutics appoints chief commercial officer
South Plainfield-based PTC Therapeutics, Inc. announced Tuesday the appointment of Mark A. Rothera as chief commercial officer, responsible for global commercial functions supporting PTC's pipeline, including the investigational new drug ataluren.
Read More »BD receives FDA approval for injectable drug
BD Rx Inc., a subsidiary of BD, announced Tuesday that the U.S. Food and Drug Administration has approved the second drug to be offered in the company’s line of ready-to-administer prefilled generic injectables.
Read More »AIDS organization selects Armada as primary purchasing partner
Florham Park-based Armada Health Care, a specialty pharmacy group purchasing and channel management organization, announced Monday that the AIDS Healthcare Foundation has chosen Armada to be its primary purchasing partner.
Read More »N.J. biopharma company seeks more funding for ricin vaccine after tainted letters
Soligenix, a biopharmaceutical company in Princeton, received new attention this week after ricin was found in letters mailed to several government officials including President Obama.
Read More »Horizon’s credit rating upgraded
Standard & Poor's upgraded Horizon Blue Cross Blue Shield of New Jersey's financial rating from “A -“ to “A” Thursday.
Read More »